Effects of hydralazine in obesity-related hypertension

被引：0
|
作者：
Carroll, JF [1 ]
King, JW [1 ]
Cohen, JS [1 ]
机构：
[1] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA
来源：
FASEB JOURNAL | 2003年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1236 / A1236
页数：1
相关论文
共 50 条
  • [41] THE ZUCKER RAT AS A MODEL OF OBESITY-RELATED HYPERTENSION
    KURTZ, TW
    MORRIS, RC
    PERSHADSINGH, HA
    HYPERTENSION, 1988, 12 (03) : 354 - 354
  • [42] Uric acid level is one of the predictors of hypertension, obesity and obesity-related hypertension
    Masuo, K
    Mikami, H
    Ogihara, T
    Tuck, ML
    HYPERTENSION, 2002, 40 (03) : 385 - 385
  • [43] Mechanisms of sympathetic activation in obesity-related hypertension
    Esler, Murray
    Straznicky, Nora
    Eikelis, Nina
    Masuo, Kazuko
    Lambert, Gavin
    Lambert, Elisabeth
    HYPERTENSION, 2006, 48 (05) : 787 - 796
  • [44] Hyperleptinemia as a risk factor in obesity-related hypertension
    Alvarez-Aguilar, C
    Mondragón-Jiménez, LI
    Ramírez-Enríquez, J
    Gómez-García, A
    Paniagua-Sierra, R
    Amato, D
    MEDICINA CLINICA, 2004, 123 (20): : 766 - 769
  • [45] Highlights of mechanisms and treatment of obesity-related hypertension
    Elham Shams
    Vijayvardhan Kamalumpundi
    Joshua Peterson
    Ronaldo Altenburg Gismondi
    Wille Oigman
    Marcelo Lima de Gusmão Correia
    Journal of Human Hypertension, 2022, 36 : 785 - 793
  • [46] Pathophysiological role of leptin in obesity-related hypertension
    Aizawa-Abe, M
    Ogawa, Y
    Masuzaki, H
    Ebihara, K
    Satoh, N
    Iwai, H
    Matsuoka, N
    Hayashi, T
    Hosoda, K
    Inoue, G
    Yoshimasa, Y
    Nakao, K
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09): : 1243 - 1252
  • [47] Increased circulating endothelin-1 in obesity-related hypertension, but not in obesity or hypertension alone
    Lilyasan, Oktavia
    Kosasih, Adrianus
    Liasturti, Lies D.
    Librantoro
    Gunawan, I. R.
    Idham, Idris
    Raharjo, Sunu B.
    Harimurti, Ganesja M.
    CIRCULATION, 2007, 116 (16) : 341 - 341
  • [48] Optimal treatment of obesity-related hypertension - The Hypertension-Obesity-Sibutramine (HOS) Study
    Scholze, Juergen
    Grimm, Elmar
    Herrmann, Dana
    Unger, Thomas
    Kintscher, Ulrich
    CIRCULATION, 2007, 115 (15) : 1991 - 1998
  • [49] Sympathoinhibitory signals from the gut and obesity-related hypertension
    Daniela M. Sartor
    Clinical Autonomic Research, 2013, 23 : 33 - 39
  • [50] PATHOPHYSIOLOGY AND TREATMENT OF THE OBESITY-RELATED ARTERIAL-HYPERTENSION
    KOLANOWSKI, J
    ACTA CLINICA BELGICA, 1992, 47 : 18 - 25
12345